Full coverage, partial coverage, no coverage for growth hormone treatment: Madison insurance choices as a microcosm

N. Fost, L. Fleming, D. Brock, M. Kaufman, M. MacGillivray, D. Sandberg, J. Fox, R. Rosenfeld, T. Lipman, M. Pauly, D. B. Allen

Research output: Contribution to journalArticle

Abstract

HMOs differ in their policies on reimbursement for growth hormone prescriptions. Even with one city, policies range from full reimbursement, to 50% co-pay, to no reimbursement. Presently, decisions are made on a case by case basis, relying on a wide range of criteria. These include FDA approval for the indication, opinions by clinical experts, literature review of likely benefit, definition of disease, cost, availability of alternatives, concerns about adverse selection, whether employers are willing to purchase coverage, whether the treatment is investigational, and whether it is a "medical necessity" - although the definition of that term is unclear.

Original languageEnglish (US)
Pages (from-to)37S-41S
JournalEndocrinologist
Volume11
Issue number4 SUPPL.
StatePublished - Jan 1 2001

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Fingerprint Dive into the research topics of 'Full coverage, partial coverage, no coverage for growth hormone treatment: Madison insurance choices as a microcosm'. Together they form a unique fingerprint.

  • Cite this

    Fost, N., Fleming, L., Brock, D., Kaufman, M., MacGillivray, M., Sandberg, D., Fox, J., Rosenfeld, R., Lipman, T., Pauly, M., & Allen, D. B. (2001). Full coverage, partial coverage, no coverage for growth hormone treatment: Madison insurance choices as a microcosm. Endocrinologist, 11(4 SUPPL.), 37S-41S.